Ciprofloxacin Hydrochloride; Fluocinolone Acetonide Patent Expiration

Ciprofloxacin Hydrochloride; Fluocinolone Acetonide is Used for treating acute otitis media. It was first introduced by Laboratorios Salvat Sa in its drug Otovel on Apr 29, 2016.


Ciprofloxacin Hydrochloride; Fluocinolone Acetonide Patents

Given below is the list of patents protecting Ciprofloxacin Hydrochloride; Fluocinolone Acetonide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Otovel US8932610 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation Mar 24, 2030 Laboratorios Salvat



Ciprofloxacin Hydrochloride; Fluocinolone Acetonide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List